Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparox: Paroxetine and Exercise in Panic Disorder
NCT00540098Phase 4Completed
- Sponsor
- Georg-August-Universität Göttingen
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of paroxetine in panic disorder (4 arms), sponsored by Georg-August-Universität Göttingen. Primary endpoints: Panic and Agoraphobia Scale at 10 weeks and Clinical Global Impression at 10 weeks. Started Sep 2001; status: completed.
02
Drugs
paroxetine
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00540098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540098.